These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36244346)

  • 1. Open-source automated insulin delivery in type 1 diabetes-the evidence is out there.
    Hussain S; Lal RA; Braune K
    Lancet Diabetes Endocrinol; 2022 Dec; 10(12):835-836. PubMed ID: 36244346
    [No Abstract]   [Full Text] [Related]  

  • 2. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency.
    Klonoff DC; Shang T; Zhang J
    J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and Future of Automated Insulin Delivery (AID) Systems.
    Garg SK; McVean JJ
    Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
    [No Abstract]   [Full Text] [Related]  

  • 4. Do-It-Yourself Automated Insulin Delivery: A Position Statement.
    ; Halperin IJ; Chambers A; Covello L; Farnsworth K; Morrison AE; Schuklenk U; Witteman HO; Senior P; ; Bajaj HS; Barnes T; Gilbert J; Honshorst K; Kim J; Lewis J; MacDonald B; Mackay D; Mansell K; Rabi D; Senior P; Sherifali D
    Can J Diabetes; 2023 Jul; 47(5):381-388. PubMed ID: 37532365
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the Interoperable Artificial Pancreas System for Type 1 Diabetes Management During Psychological Stress.
    Pinsker JE; Deshpande S; McCrady-Spitzer S; Church MM; Kaur RJ; Perez J; Desjardins D; Piper M; Reid C; Doyle FJ; Kudva YC; Dassau E
    J Diabetes Sci Technol; 2021 Jan; 15(1):184-185. PubMed ID: 32783473
    [No Abstract]   [Full Text] [Related]  

  • 6. Large Treatment Effects With Automated Insulin Delivery System.
    Slomski A
    JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantifying Input Behaviors That Influence Clinical Outcomes in Diabetes and Other Chronic Illnesses.
    Lewis DM
    J Diabetes Sci Technol; 2022 May; 16(3):786-787. PubMed ID: 34971322
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
    Müller-Korbsch M; Frühwald L; Kietaibl A
    J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 1 diabetes: NICE recommends new "artificial pancreas" technology.
    Iacobucci G
    BMJ; 2023 Jan; 380():55. PubMed ID: 36627118
    [No Abstract]   [Full Text] [Related]  

  • 10. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status and Emerging Options for Automated Insulin Delivery Systems.
    Forlenza GP; Lal RA
    Diabetes Technol Ther; 2022 May; 24(5):362-371. PubMed ID: 35099302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).
    Lewis D
    J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    Harris E
    JAMA; 2023 Apr; 329(15):1249. PubMed ID: 36988977
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
    Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ
    Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916
    [No Abstract]   [Full Text] [Related]  

  • 15. Type 1 diabetes: from the dream of automated insulin delivery to a fully artificial pancreas.
    Phillip M; Kowalski A; Battelino T
    Nat Med; 2024 May; 30(5):1232-1234. PubMed ID: 38448742
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of Advanced Hybrid Closed-Loop System in a Patient with Pancreas Cancer.
    Hacisahinogullari H; Caklili OT; Saribeyliler G; Rasulova N; Selcukbiricik O; Gul N; Uzum AK; Karsidag K
    Diabetes Technol Ther; 2022 Sep; 24(9):675-676. PubMed ID: 35349364
    [No Abstract]   [Full Text] [Related]  

  • 17. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus.
    Sachdeva P; M AR; Shukla R; Sahani A
    J Med Eng Technol; 2022 Nov; 46(8):693-702. PubMed ID: 35801984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports.
    Lemieux P; Yamamoto JM; Donovan LE
    Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862
    [No Abstract]   [Full Text] [Related]  

  • 19. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.